This page presents data on the content and variability of samples that were “sold as fentanyl” in order to provide some insights into unregulated fentanyl.
The first figure provides information on the content of samples sold as fentanyl over the past four quarters. 2024 fourth quarter data are incomplete but include approximately half the quarter--the last sample in this analysis was submitted 2 December 2024. Click on 'Samples sold as fentanyl' in the legend to turn on that series and see the total samples sold as fentanyl included in each quarter. For samples sold as fentanyl, we include both fentanyl itself and fentanyl analogues to be the "expected" drug. Additional data notes are at the bottom of this page and the details on drug categories are available here.
To explore the variability of samples we provide data in the next figure including the median number of substance results (the count of chemicals found in a given sample) and the median number of fentanyls and fentanyl precursors found. Higher numbers represent more chemicals being detected. As a measure of variability, the standard deviation of the result count by quarter is shown, with higher numbers indicating more variability in the number of chemical results among samples in the quarter.
Drug testing sites can do little about potential cross-contamination: The container a client used may or may not have been used before. Therefore, any unusual combination may be due to cross-contamination and not represent drugs actually sold together. For more details on drug categories named, click here. The metrics presented here include:
Medians are more stable measures of central tendency than averages. If quarter 1 ranges from 2 to 8 and quarter 2 ranges from 2 to 16, the median--the middle value--might be no different but the mean for quarter 2 will be pulled up by the presence of even a single extreme value (e.g., 16). The standard deviation would increase in quarter 2 in this example.